Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Frederik B. Thomsen, Marta K. Mikkelsen, Rikke B. Hansen, Andrea H. Krug, Anders Glenthøj, Pär Stattin & Klaus Brasso. (2016) Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center. Acta Oncologica 55:12, pages 1456-1460.
Read now
Read now
Anders Bjartell, Matteo Bottai, Josefin Persson, Ola Bratt, Jan-Erik Damber, Pär Stattin & Olof Akre. (2016) Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort. Scandinavian Journal of Urology 50:4, pages 255-259.
Read now
Read now
Carl Kilander, Fredrik Mattsson, Yunxia Lu, Rickard Ljung, Jesper Lagergren & Omid Sadr-Azodi. (2016) Exogenous estrogen and the risk of biliary tract cancer – a population-based study in a cohort of Swedish men treated for prostate cancer. Acta Oncologica 55:7, pages 846-850.
Read now
Read now
Michael Jan, Stephanie E. Bonn, Arvid Sjölander, Fredrik Wiklund, Pär Stattin, Erik Holmberg, Henrik Grönberg & Katarina Bälter. (2016) The roles of stress and social support in prostate cancer mortality. Scandinavian Journal of Urology 50:1, pages 47-55.
Read now
Read now
Erin L. Ohmann, Stacy Loeb, David Robinson, Anna Bill-Axelson, Anders Berglund & Pär Stattin. (2014) Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories. Scandinavian Journal of Urology 48:5, pages 426-435.
Read now
Read now
Afsaneh Hayat Roshanai, Karin Nordin & Gunilla Berglund. (2013) Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer. Acta Oncologica 52:8, pages 1602-1608.
Read now
Read now
Jon fridriksson, Katarina Gunseus & Pär stattin. (2012)
Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: A study from the National Prostate Cancer Register (NPCR) of Sweden
. Scandinavian Journal of Urology and Nephrology 46:5, pages 326-331.
Read now
Read now
Sara Jonmarker Jaraj, Martin Augsten, Lars Häggarth, Kenneth Wester, Fredrik Pontén, Arne Östman & Lars Egevad. (2011) GAD1 is a biomarker for benign and malignant prostatic tissue. Scandinavian Journal of Urology and Nephrology 45:1, pages 39-45.
Read now
Read now
Ola Bratt, Anders Berglund, Jan Adolfsson, Jan-Erik Johansson, Magnus Törnblom & Pär Stattin. (2010) Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: A population-based study from the National Prostate Cancer Register of Sweden. Scandinavian Journal of Urology and Nephrology 44:6, pages 384-390.
Read now
Read now
Eva Hagel, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Jan-Erik Johansson, Jan Adolfsson, Mats Lambe & Pär Stattin. (2009) PCBaSe Sweden: A register-based resource for prostate cancer research. Scandinavian Journal of Urology and Nephrology 43:5, pages 342-349.
Read now
Read now
Sigrid Carlsson, Jan Adolfsson, Ola Bratt, Jan-Erik Johansson, Christer Ahlstrand, Erik Holmberg, Pär Stattin & Jonas Hugosson. (2009) Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. Scandinavian Journal of Urology and Nephrology 43:5, pages 350-356.
Read now
Read now
Sonny Schelin, Mikael Madsen, Elisabeth Palmqvist, Erik Mäkelä, Claes Klintenberg & Gunnar Aus. (2009) Long-term follow-up after triple treatment of prostate cancer stage pT3. Scandinavian Journal of Urology and Nephrology 43:3, pages 186-191.
Read now
Read now
Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst, Jouko Viitanen, Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst & Jouko Viitanen. (2008) Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology 42:3, pages 220-229.
Read now
Read now
Articles from other publishers (78)
Marcus Westerberg, Rolf Larsson, Lars Holmberg, Pär Stattin & Hans Garmo. (2020) Simulation model of disease incidence driven by diagnostic activity. Statistics in Medicine 40:5, pages 1172-1188.
Crossref
Crossref
Renata Zelic, Daniela Zugna, Matteo Bottai, Ove Andrén, Jonna Fridfeldt, Jessica Carlsson, Sabina Davidsson, Valentina Fiano, Michelangelo Fiorentino, Francesca Giunchi, Chiara Grasso, Luca Lianas, Cecilia Mascia, Luca Molinaro, Gianluigi Zanetti, Lorenzo Richiardi, Andreas Pettersson & Olof Akre. (2019) Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study. American Journal of Epidemiology 188:6, pages 1165-1173.
Crossref
Crossref
Doo Yong Chung, Hyeok Jun Goh, Dong Hoon Koh, Min Seok Kim, Jong Soo Lee, Won Sik Jang & Young Deuk Choi. (2018) Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer. PLOS ONE 13:12, pages e0210037.
Crossref
Crossref
Miriam Wanner, Aline Richard, Katarina Matthes, Laura Ortelli, Matthias Lorez, Dimitri Korol, Andrea Bordoni & Sabine Rohrmann. (2017) Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage. Cancer Causes & Control 29:2, pages 269-277.
Crossref
Crossref
Ji Eun Heo, Hyun Kyu Ahn, Jinu Kim, Byung Ha Chung & Kwang Suk Lee. (2018) Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center. Journal of Korean Medical Science 33:6.
Crossref
Crossref
Prabhakar RajanPrasanna SooriakumaranTommy NybergOlof AkreStefan CarlssonLars EgevadGunnar SteineckN. Peter Wiklund. (2017) Effect of Comorbidity on Prostate Cancer–Specific Mortality: A Prospective Observational Study. Journal of Clinical Oncology 35:31, pages 3566-3574.
Crossref
Crossref
Mette H. Møller, Ivar S. Kristiansen, Christian Beisland, Jarle Rørvik & Henrik Støvring. (2016) Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study. BJU International 118:4, pages 547-555.
Crossref
Crossref
Mieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, Olof Akre, Lars Holmberg, Hans Garmo & Pär Stattin. (2016) Causes of death in men with localized prostate cancer: a nationwide, population-based study. BJU International 117:3, pages 507-514.
Crossref
Crossref
Kiranpreet K. Khurana & Joseph P. Alukal. 2016. Cancer and Fertility. Cancer and Fertility
1
10
.
Ola Bratt, Yasin Folkvaljon, Stacy Loeb, Laurence Klotz, Lars Egevad & Pär Stattin. (2015) Upper limit of cancer extent on biopsy defining very low-risk prostate cancer. BJU International 116:2, pages 213-219.
Crossref
Crossref
Yunxia LuRickard Ljung, Anna MartlingMats Lindblad. (2015) Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort. Cancer Control 22:2, pages 263-270.
Crossref
Crossref
Anna Martling. (2015) Does Androgen Deprivation Therapy for Prostate Cancer Increase the Risk of Colorectal Cancer?. Cancer Control 22:2, pages 261-262.
Crossref
Crossref
Lodovico Balducci & Julio M. Pow-Sang. (2015) Colorectal Cancer: The Last Nail in the Coffin for Androgen Deprivation Therapy for Prostate Cancer?. Cancer Control 22:2, pages 259-260.
Crossref
Crossref
Sara Wirén, Linda Drevin, Olof Akre, David Robinson & Pär Stattin. (2014) Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study. PLoS ONE 9:10, pages e110506.
Crossref
Crossref
Karl-Johan Lundström, Linda Drevin, Stefan Carlsson, Hans Garmo, Stacy Loeb, Pär Stattin & Anna Bill-Axelson. (2014) Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy. Journal of Urology 192:4, pages 1116-1122.
Crossref
Crossref
Hanna Nilsson, Johan Stranne, Pär Stattin & Pär Nordin. (2014) Incidence of Groin Hernia Repair After Radical Prostatectomy. Annals of Surgery 259:6, pages 1223-1227.
Crossref
Crossref
R. Mathieu, Y. Tibari, G. Verhoest, S. Vincendeau, A. Manunta, N. Rioux-Leclercq & K. Bensalah. (2014) Étude comparée des résultats histologiques de résection et de biopsies de prostate. Progrès en Urologie 24:6, pages 374-378.
Crossref
Crossref
Ayal A. Aizer, Jonathan J. Paly, M. Dror Michaelson, Sandhya K. Rao, Paul L. Nguyen, Irving D. Kaplan, Andrzej Niemierko, Aria F. Olumi & Jason A. Efstathiou. (2014) Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer. Journal of Oncology Practice 10:2, pages 107-112.
Crossref
Crossref
Robert Karlsson, Markus Aly, Mark Clements, Lilly Zheng, Jan Adolfsson, Jianfeng Xu, Henrik Grönberg & Fredrik Wiklund. (2014) A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk. European Urology 65:1, pages 169-176.
Crossref
Crossref
D C Greenberg, K A Wright, A Lophathanon, K R Muir & V J Gnanapragasam. (2013) Changing presentation of prostate cancer in a UK population – 10 year trends in prostate cancer risk profiles in the East of England. British Journal of Cancer 109:8, pages 2115-2120.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Karl Michaëlsson, Andreas Thorstenson, Olof Akre, Pär Stattin, Lars Holmberg & Jan Adolfsson. (2013) Mortality following Hip Fracture in Men with Prostate Cancer. PLoS ONE 8:9, pages e74492.
Crossref
Crossref
Signe Benzon Larsen, Klaus Brasso, Peter Iversen, Jane Christensen, Michael Christiansen, Sigrid Carlsson, Hans Lilja, Søren Friis, Anne Tjønneland & Susanne Oksbjerg Dalton. (2013) Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort. European Journal of Cancer 49:14, pages 3041-3048.
Crossref
Crossref
Sara M. Wirén, Linda I. Drevin, Sigrid V. Carlsson, Olof Akre, Erik C. Holmberg, David E. Robinson, Hans G. Garmo & Pär E. Stattin. (2013) Fatherhood status and risk of prostate cancer: Nationwide, population‐based case–control study. International Journal of Cancer 133:4, pages 937-943.
Crossref
Crossref
M. Van Hemelrijck, A. Wigertz, F. Sandin, H. Garmo, K. Hellstrom, P. Fransson, A. Widmark, M. Lambe, J. Adolfsson, E. Varenhorst, J.-E. Johansson, P. Stattin, L. Drevin, A. Bill-Axelson, D. Robinson & O. Akre. (2012) Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. International Journal of Epidemiology 42:4, pages 956-967.
Crossref
Crossref
Andrea Salonia, Paolo Capogrosso, Fabio Castiglione, Andrea Russo, Andrea Gallina, Matteo Ferrari, Maria Chiara Clementi, Giulia Castagna, Alberto Briganti, Francesco Cantiello, Rocco Damiano & Francesco Montorsi. (2013) Sperm banking is of key importance in patients with prostate cancer. Fertility and Sterility 100:2, pages 367-372.e1.
Crossref
Crossref
Klaus Brasso, Inga Jóna Ingimarsdóttir, Ea Rusch, Gerda Engholm, Jan Adolfsson, Laufey Tryggvadóttir, Eiríkur Jónsson, Anna Bill-Axelson, Erik Holmberg & Hans Henrik Storm. (2013) Differences in survival from prostate cancer in Denmark, Iceland and Sweden. European Journal of Cancer 49:8, pages 1984-1992.
Crossref
Crossref
Sam Ladjevardi, Anders Berglund, Eberhard Varenhorst, Ola Bratt, Anders Widmark & Gabriel Sandblom. (2012)
Treatment with curative intent and survival in men with high‐risk prostate cancer. A population‐based study of 11 380 men with serum
PSA
level 20–100 ng/
mL
. BJU International 111:3, pages 381-388.
Crossref
Crossref
Sandra Eloranta, Jan Adolfsson, Paul C. Lambert, Pär Stattin, Olof Akre, Therese M-L. Andersson & Paul W. Dickman. (2013) How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden. Cancer Causes & Control 24:3, pages 505-515.
Crossref
Crossref
Stacy Loeb, Linda Drevin, David Robinson, Erik Holmberg, Sigrid Carlsson, Mats Lambe & Pär Stattin. (2012) Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes & Control 24:2, pages 383-390.
Crossref
Crossref
Jennifer R. Rider, Fredrik Sandin, Ove Andrén, Peter Wiklund, Jonas Hugosson & Pär Stattin. (2013) Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study. European Urology 63:1, pages 88-96.
Crossref
Crossref
Ruth Etzioni, Lorelei Mucci, Shu Chen, Jan-Erik Johansson, Katja Fall & Hans-Olov Adami. (2012) Increasing Use of Radical Prostatectomy for Nonlethal Prostate Cancer in Sweden. Clinical Cancer Research 18:24, pages 6742-6747.
Crossref
Crossref
Mieke Van Hemelrijck, Linda Drevin, Lars Holmberg, Hans Garmo, Jan Adolfsson & Pär Stattin. (2012) Primary cancers before and after prostate cancer diagnosis. Cancer 118:24, pages 6207-6216.
Crossref
Crossref
Cynthia Chen, Nasheen Naidoo, Qian Yang, Mikael Hartman, Helena M Verkooijen, En Yun Loy, Christine Bouchardy, Kee Seng Chia & Sin Eng Chia. (2012) A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006. BMC Cancer 12:1.
Crossref
Crossref
B. Grundmark, H. Garmo, B. Zethelius, P. Stattin, M. Lambe & L. Holmberg. (2012) Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden. European Journal of Clinical Pharmacology 68:12, pages 1619-1630.
Crossref
Crossref
K. Fredrik Jansson, Olof Akre, Hans Garmo, Anna Bill-Axelson, Jan Adolfsson, Pär Stattin & Ola Bratt. (2012) Concordance of Tumor Differentiation Among Brothers with Prostate Cancer. European Urology 62:4, pages 656-661.
Crossref
Crossref
Andreas Thorstenson, Ola Bratt, Olof Akre, Henrik Hellborg, Lars Holmberg, Mats Lambe, Anna Bill-Axelson, Pär Stattin & Jan Adolfsson. (2012) Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden. European Journal of Cancer 48:11, pages 1672-1681.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, Pär Stattin & Jan Adolfsson. (2012) Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden. European Urology 61:4, pages 690-700.
Crossref
Crossref
L. Holmberg, D. Robinson, F. Sandin, F. Bray, K.M. Linklater, Å. Klint, P.C. Lambert, J. Adolfsson, F.C. Hamdy, J. Catto & H. Møller. (2012) A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study. Cancer Epidemiology 36:1, pages e7-e12.
Crossref
Crossref
David Robinson, Hans Garmo, Bertil Lindahl, Mieke Van Hemelrijck, Jan Adolfsson, Ola Bratt, Lars Holmberg & Pär Stattin. (2011) Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. International Journal of Cancer 130:2, pages 478-487.
Crossref
Crossref
Anna L. Gharibyan, Dina Raveh & Ludmilla A. Morozova-Roche. 2012. Amyloid Proteins. Amyloid Proteins
387
401
.
Robert Szulkin, Erik Holmberg, Pär Stattin, Jianfeng Xu, Sigun Zheng, Juni Palmgren, Henrik Grönberg & Fredrik Wiklund. (2011) Prostate cancer risk variants are not associated with disease progression. The Prostate 72:1, pages 30-39.
Crossref
Crossref
Mattias Johansson, Benny Holmström, Sally R. Hinchliffe, Anders Bergh, Ulf‐Håkan Stenman, Göran Hallmans, Fredrik Wiklund & Pär Stattin. (2011) Combining 33 genetic variants with prostate‐specific antigen for prediction of prostate cancer: Longitudinal study. International Journal of Cancer 130:1, pages 129-137.
Crossref
Crossref
Brian S Buckley, Marie Carmela M Lapitan, Colin R Simpson & Aziz Sheikh. (2011) Risk of prostate cancer associated with benign prostate disease: a primary care case–control study. British Journal of General Practice 61:592, pages e684-e691.
Crossref
Crossref
Kari Hemminki, Jianguang Ji, Kristina Sundquist, Jan Sundquist & Xiangdong Liu. (2011) Screening detected prostate cancers in type 2 diabetics. International Journal of Cancer 129:9, pages 2305-2307.
Crossref
Crossref
Håkan Jonsson, Benny Holmström, Stephen W. Duffy & Pär Stattin. (2011) Uptake of prostate‐specific antigen testing for early prostate cancer detection in Sweden. International Journal of Cancer 129:8, pages 1881-1888.
Crossref
Crossref
Daniel W. Lin, Liesel M. FitzGerald, Rong Fu, Erika M. Kwon, Siqun Lilly Zheng, Suzanne Kolb, Fredrik Wiklund, Pär Stattin, William B. Isaacs, Jianfeng Xu, Elaine A. Ostrander, Ziding Feng, Henrik Grönberg & Janet L. Stanford. (2011)
Genetic Variants in the
LEPR
,
CRY1
,
RNASEL
,
IL4
, and
ARVCF
Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality
. Cancer Epidemiology, Biomarkers & Prevention 20:9, pages 1928-1936.
Crossref
Crossref
Olof Akre, Hans Garmo, Jan Adolfsson, Mats Lambe, Ola Bratt & Pär Stattin. (2011) Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden. European Urology 60:3, pages 554-563.
Crossref
Crossref
Anna Bill-Axelson, Hans Garmo, Ullakarin Nyberg, Mats Lambe, Ola Bratt, Pär Stattin, Jan Adolfsson & Gunnar Steineck. (2011) Psychiatric treatment in men with prostate cancer – Results from a Nation-wide, population-based cohort study from PCBaSe Sweden. European Journal of Cancer 47:14, pages 2195-2201.
Crossref
Crossref
Anders Bjartell. (2011) Genetic Markers and the Risk of Developing Prostate Cancer. European Urology 60:1, pages 29-31.
Crossref
Crossref
Markus Aly, Fredrik Wiklund, Jianfeng Xu, William B. Isaacs, Martin Eklund, Mauro D'Amato, Jan Adolfsson & Henrik Grönberg. (2011) Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study. European Urology 60:1, pages 21-28.
Crossref
Crossref
Hans Lilja, Angel M. Cronin, Anders Dahlin, Jonas Manjer, Peter M. Nilsson, James A. Eastham, Anders S. Bjartell, Peter T. Scardino, David Ulmert & Andrew J. Vickers. (2010) Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50. Cancer 117:6, pages 1210-1219.
Crossref
Crossref
Mara M Epstein, Julie L Kasperzyk, Ove Andrén, Edward L Giovannucci, Alicja Wolk, Niclas Håkansson, Swen-Olof Andersson, Jan-Erik Johansson, Katja Fall & Lorelei A Mucci. (2011) Dietary zinc and prostate cancer survival in a Swedish cohort. The American Journal of Clinical Nutrition 93:3, pages 586-593.
Crossref
Crossref
Anders Berglund, Hans Garmo, Carol Tishelman, Lars Holmberg, Pär Stattin & Mats Lambe. (2011) Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden. Journal of Urology 185:3, pages 833-840.
Crossref
Crossref
Benny Holmström, Erik Holmberg, Lars Egevad, Jan Adolfsson, Jan-Erik Johansson, Jonas Hugosson & Pär Stattin. (2010) Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. Journal of Urology 184:4, pages 1322-1327.
Crossref
Crossref
Tanja Stocks, Maria‐Pia Hergens, Anders Englund, Weimin Ye & Pär Stattin. (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. International Journal of Cancer 127:7, pages 1660-1668.
Crossref
Crossref
O. Bratt, H. Garmo, J. Adolfsson, A. Bill-Axelson, L. Holmberg, M. Lambe & P. Stattin. (2010) Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates. JNCI Journal of the National Cancer Institute 102:17, pages 1336-1343.
Crossref
Crossref
Mara S. Meyer, Lorelei A. Mucci, Swen-Olof Andersson, Ove Andrén, Jan-Erik Johansson, Steinar Tretli & Hans-Olov Adami. (2010) Homogeneous Prostate Cancer Mortality in the Nordic Countries Over Four Decades. European Urology 58:3, pages 427-432.
Crossref
Crossref
Mieke Van HemelrijckHans GarmoLars HolmbergErik IngelssonOla BrattAnna Bill-AxelsonMats LambePär StattinJan Adolfsson. (2010) Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden. Journal of Clinical Oncology 28:21, pages 3448-3456.
Crossref
Crossref
P. Stattin, E. Holmberg, J.-E. Johansson, L. Holmberg, J. Adolfsson & J. Hugosson. (2010) Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study. JNCI Journal of the National Cancer Institute 102:13, pages 950-958.
Crossref
Crossref
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Erik Ingelsson, Mats Lambe, Pär Stattin & Lars Holmberg. (2010) Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. The Lancet Oncology 11:5, pages 450-458.
Crossref
Crossref
Eivor Hernes, Anne Kyrdalen, Rune Kvåle, Einar Hem, Olbjørn Klepp, Karol Axcrona & Sophie D. Fosså. (2010) Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry. BJU International 105:6, pages 805-811.
Crossref
Crossref
Anna Bill-Axelson, Hans Garmo, Mats Lambe, Ola Bratt, Jan Adolfsson, Ullakarin Nyberg, Gunnar Steineck & Pär Stattin. (2010) Suicide Risk in Men with Prostate-Specific Antigen–Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden. European Urology 57:3, pages 390-395.
Crossref
Crossref
Jianfeng Xu, Siqun Lilly Zheng, Sarah D. IsaacsKathleen E. WileyFredrik WiklundJielin Sun, A. Karim Kader, Ge Li, Lina D. Purcell, Seong-Tae Kim, Fang-Chi HsuPär StattinJonas HugossonJan Adolfsson, Patrick C. WalshJeffrey M. Trent, David Duggan, John Carpten, Henrik GrönbergWilliam B. Isaacs. (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proceedings of the National Academy of Sciences 107:5, pages 2136-2140.
Crossref
Crossref
Mats Olsson, Lena Ekström, Jenny Schulze, Anders Kjellman, Olof Akre, Anders Rane & Ove Gustafsson. (2009) Radical prostatectomy: Influence on serum and urinary androgen levels. The Prostate 70:2, pages 200-205.
Crossref
Crossref
J. Jegu, B. Tretarre, M. Velten, A.-V. Guizard, A. Danzon, A. Buemi, M. Colonna, A.-M. Kadi-Hanifi, O. Ganry, F. Molinie, S. Bara, X. Rebillard & P. Grosclaude. (2010) Le cancer de la prostate en France en 2001 : état des pratiques et facteurs associés à la réalisation d’une prostatectomie totale. Progrès en Urologie 20:1, pages 56-64.
Crossref
Crossref
N Orsini, R Bellocco, M Bottai, M Pagano, S-O Andersson, J-E Johansson, E Giovannucci & A Wolk. (2009) A prospective study of lifetime physical activity and prostate cancer incidence and mortality. British Journal of Cancer 101:11, pages 1932-1938.
Crossref
Crossref
Andrea Salonia, Andrea Gallina, Rayan Matloob, Lorenzo Rocchini, Antonino Saccà, Firas Abdollah, Renzo Colombo, Nazareno Suardi, Alberto Briganti, Giorgio Guazzoni, Patrizio Rigatti & Francesco Montorsi. (2009) Is Sperm Banking of Interest to Patients With Nongerm Cell Urological Cancer Before Potentially Fertility Damaging Treatments?. Journal of Urology 182:3, pages 1101-1107.
Crossref
Crossref
Kiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, Vaibhav Srivastava, Andrei Shchukarev, Ann-Christin Brorsson, Gian Gaetano Tartaglia, Thomas Vogl, Rakez Kayed, Gunnar Wingsle, Jan Olsson, Christopher M. Dobson, Anders Bergh, Fredrik Elgh & Ludmilla A. Morozova-Roche. (2009) Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate. PLoS ONE 4:5, pages e5562.
Crossref
Crossref
Mattias Johansson, Bethany Van Guelpen, Stein Emil Vollset, Johan Hultdin, Anders Bergh, Tim Key, Øivind Midttun, Göran Hallmans, Per M. Ueland & Pär Stattin. (2009) One-Carbon Metabolism and Prostate Cancer Risk: Prospective Investigation of Seven Circulating B Vitamins and Metabolites. Cancer Epidemiology, Biomarkers & Prevention 18:5, pages 1538-1543.
Crossref
Crossref
Fredrik E. Wiklund, Hans-Olov Adami, Sigun L. Zheng, Pär Stattin, William B. Isaacs, Henrik Grönberg & Jianfeng Xu. (2009) Established Prostate Cancer Susceptibility Variants are not Associated with Disease Outcome. Cancer Epidemiology, Biomarkers & Prevention 18:5, pages 1659-1662.
Crossref
Crossref
Fredrik Wiklund, S. Lilly Zheng, Jielin Sun, Hans‐Olov Adami, Hans Lilja, Fang‐Chi Hsu, Pär Stattin, Jan Adolfsson, Scott D. Cramer, David Duggan, John D. Carpten, Bao‐Li Chang, William B. Isaacs, Henrik Grönberg & Jianfeng Xu. (2008) Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. The Prostate 69:4, pages 419-427.
Crossref
Crossref
S. Lilly Zheng, Jielin Sun, Fredrik Wiklund, Zhengrong Gao, Pär Stattin, Lina D. Purcell, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Jan Adolfsson, Jan-Erik Johansson, Aubrey R. Turner, Tamara S. Adams, Wennuan Liu, David Duggan, John D. Carpten, Bao-Li Chang, William B. Isaacs, Jianfeng Xu & Henrik Grönberg. (2009) Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen. Clinical Cancer Research 15:3, pages 1105-1111.
Crossref
Crossref
Jan Adolfsson. (2009) Re: Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer: Part 2. Final Evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. European Urology 55:2, pages 525.
Crossref
Crossref
Pär Stattin, Erik Holmberg, Ola Bratt, Jan Adolfsson, Jan-Erik Johansson & Jonas Hugosson. (2008) Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden. Journal of Urology 180:6, pages 2423-2430.
Crossref
Crossref
Jan Adolfsson. (2008) Editorial Comment on: Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance. European Urology 54:6, pages 1304-1305.
Crossref
Crossref
Jan Adolfsson. (2008) Watchful waiting and active surveillance: the current position. BJU International 102:1, pages 10-14.
Crossref
Crossref
Jan Adolfsson. (2008) The Management of Category T1a–T1b (Incidental) Prostate Cancer: Can We Predict Who Needs Treatment?. European Urology 54:1, pages 16-18.
Crossref
Crossref
Axel Heidenreich. (2008) Radical Prostatectomy in 2007: Oncologic Control and Preservation of Functional Integrity. European Urology 53:5, pages 877-879.
Crossref
Crossref